Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
Palmer
Roger David
RD
Department of Paediatric Oncology, Addenbrooke's Hospital, Cambridge, United Kingdom. rdpalmer@doctors.org.uk
Williams
Denise Mary
DM
D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D018197:Hepatoblastoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary; D000509:alpha-Fetoproteins
D000972:Antineoplastic Agents, Phytogenic; D000509:alpha-Fetoproteins; D000077146:Irinotecan; D002166:Camptothecin